SURGICAL ONCOLOGY: Why biopsying metastatic breast cancer should be routine

Anand Sharma, Tim Crook, Alastair Thompson, Carlo Palmieri

    Research output: Contribution to journalEditorialpeer-review

    12 Citations (Scopus)

    Abstract

    The true burden of metastatic breast cancer worldwide is unknown, although there are approximately 411,000 breast cancer deaths per year worldwide. As the current median survival of newly diagnosed patients with metastatic disease is 20 months, the number of patients alive and living with advanced disease is substantial.
    Original languageEnglish
    Pages (from-to)71-74
    Number of pages4
    JournalNature Reviews Clinical Oncology
    Volume7
    Issue number2
    DOIs
    Publication statusPublished - Feb 2010

    Keywords

    • RECEPTOR
    • ESTROGEN
    • THERAPY

    Fingerprint

    Dive into the research topics of 'SURGICAL ONCOLOGY: Why biopsying metastatic breast cancer should be routine'. Together they form a unique fingerprint.

    Cite this